AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • March 13th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
Contract Type FiledMarch 13th, 2023 Company Industry JurisdictionThis Amendment to Consulting Agreement (the “Amendment”), effective as of January 1st, 2023 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.
LICENSE AGREEMENTLicense Agreement • March 13th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 13th, 2023 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made as of September 1, 2021 (the “Effective Date”), by and among Ferring International Center S.A., a company incorporated pursuant to the laws of Switzerland, having its principal place of business at Ch. De la Vergognausaz 50, 1162 Saint-Prex, Switzerland (“Ferring”) (“Licensor”), and SciVac Ltd, a company incorporated under the laws of Israel, having a place of business at 13 Gad Feinstein Rd Rehovot, 7610303 Israel (“Licensee”) and VBI Vaccines Inc. a company incorporated under the laws of British Columbia, Canada, having a place of business at 160 Second Street, Cambridge, MA 02142 (“Guarantor”).
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.Amending Agreement • March 13th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
Contract Type FiledMarch 13th, 2023 Company IndustryWHEREAS the Parties entered into an Agreement signed by the NRC on 30 March 2020, for a Project described as “COVID-19 vaccine evaluation” (hereinafter called the “Original Agreement”)
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.Amendment Agreement • March 13th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
Contract Type FiledMarch 13th, 2023 Company IndustryThis amendment agreement includes and incorporates by reference: The amendment agreement (referred to as the “Amendment Agreement”) means this Agreement Summary together with the following, which in the event of conflict shall have priority in the order set out below: - Agreed Amendments (Annex A) - Terms and Conditions of Amendment (Annex B) - the Original Agreement (as amended by any subsequent amendments mutually agreed by the parties whether listed above or not)